How to transition existing trials under EU-CTR
Related Insights
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Article
Decentralized trial tools and technologies are here to stay: A regulatory perspective
Jul 23, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Webinar
Global trial expansion: Navigating Australia & LATAM's evolving clinical research landscape
Dec 2, 2025
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct
Sep 14, 2021
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Blog
Assessing the need for comparative clinical trials in biosimilar development programs
Sep 21, 2023
Related Insights
Video
Part 3: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Article
Decentralized trial tools and technologies are here to stay: A regulatory perspective
Jul 23, 2021
Video
Part 2: Risk-based Quality Management Video (RBQM) Series
Nov 11, 2021
Webinar
Global trial expansion: Navigating Australia & LATAM's evolving clinical research landscape
Dec 2, 2025
Report
New Medicines, Novel Insights: Advancing rare disease drug development
May 22, 2023
Report
New Medicines, Novel Insights: Accelerating development of cell and gene therapies
May 22, 2023
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025
Article
Australia: The Regulatory and Reimbursement Environment
Aug 28, 2023
Article
How a joined-up development strategy pays off for early-stage biotechs
May 19, 2021
Article
Part 1 - Preparing for a Risk-Based Future: What ICH Revisions Mean for Clinical Trial Design and Conduct
Sep 14, 2021
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Blog
Assessing the need for comparative clinical trials in biosimilar development programs
Sep 21, 2023